Literature DB >> 9254061

Oxidation products of cholesteryl linoleate are resistant to hydrolysis in macrophages, form complexes with proteins, and are present in human atherosclerotic lesions.

G Hoppe1, A Ravandi, D Herrera, A Kuksis, H F Hoff.   

Abstract

Accumulation of the insoluble lipid-protein complex, ceroid, is a characteristic of atherosclerotic plaques. To determine whether deficient processing of cholesteryl esters in oxidized (ox) low density lipoprotein (LDL) contributes to ceroid formation, we studied the hydrolysis of internalized [3H] cholesteryl linoleate (CL) in oxLDL by mouse peritoneal macrophages (MPM). The hydrolysis by MPM of [3H]CL incorporated into oxLDL or LDL did not differ, suggesting that products of lipid and/or apoB oxidation had no impact on the lysosomal hydrolysis of [3H]CL. To evaluate the hydrolysis of oxCL by MPM, we subjected extensively ox[3H]CL to fractionation by TLC. The predominant fraction (D) consisted of sterols and oxysterols esterified to scission products of oxidized fatty acids containing terminal carbonyl groups, i.e., lipid core aldehydes. The extent of hydrolysis of [3H]-fraction D by MPM cultures, as well as by MPM extracts at pH 4.0, was significantly reduced when compared to the hydrolysis of intact [3H]CL. Fraction D also formed complexes with serum proteins, and the purified core aldehyde, cholesteryl 9-oxononanoate reacted with epsilon-amino group of lysines. Finally, several cholesteryl ester aldehydes were detected in lipid extracts of human atheroma. These results suggest that decomposition products of extensively oxidized cholesteryl linoleate that are also present in atherosclerotic lesions, are not adequately degraded by mouse peritoneal macrophage lysosomes and could interact with proteins to form ceroid.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9254061

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  19 in total

1.  Assessment of protein oxidation in women using raloxifene.

Authors:  U Korucuoğlu; B Ciftçi; O Gülbahar; A Biri; T Nas; R Gürsoy; A Aricioğlu
Journal:  Mol Cell Biochem       Date:  2006-08-29       Impact factor: 3.396

2.  Electrospray MS/MS reveals extensive and nonspecific oxidation of cholesterol esters in human peripheral vascular lesions.

Authors:  Patrick M Hutchins; Ernest E Moore; Robert C Murphy
Journal:  J Lipid Res       Date:  2011-08-31       Impact factor: 5.922

3.  A monoclonal antibody to assess oxidized cholesteryl esters associated with apoAI and apoB-100 lipoproteins in human plasma.

Authors:  Ayelet Gonen; Soo-Ho Choi; Phuong Miu; Colin Agatisa-Boyle; Daniel Acks; Angela M Taylor; Coleen A McNamara; Sotirios Tsimikas; Joseph L Witztum; Yury I Miller
Journal:  J Lipid Res       Date:  2018-12-18       Impact factor: 5.922

4.  The content of lipoperoxidation products in normal and atherosclerotic human aorta.

Authors:  V V Tertov; V V Kaplun; I A Mikhailova; I V Suprun; A N Orekhov
Journal:  Mol Cell Biochem       Date:  2001-09       Impact factor: 3.396

5.  Adductome-based identification of biomarkers for lipid peroxidation.

Authors:  Takahiro Shibata; Kazuma Shimizu; Keita Hirano; Fumie Nakashima; Ryosuke Kikuchi; Tadashi Matsushita; Koji Uchida
Journal:  J Biol Chem       Date:  2017-03-24       Impact factor: 5.157

6.  1 -O-alkyl-2-(omega-oxo)acyl-sn-glycerols from shark oil and human milk fat are potential precursors of PAF mimics and GHB.

Authors:  Karsten Hartvigsen; Amir Ravandi; Richard Harkewicz; Hiroshi Kamido; Klaus Bukhave; Gunhild Hølmera; Arnis Kuksis
Journal:  Lipids       Date:  2006-07       Impact factor: 1.880

7.  Glycoxidized particles mimic lipofuscin accumulation in aging eyes: a new age-related macular degeneration model in rabbits.

Authors:  Tsutomu Yasukawa; Peter Wiedemann; Stefan Hoffmann; Johannes Kacza; Wolfram Eichler; Yu-Sheng Wang; Akiko Nishiwaki; Johannes Seeger; Yuichiro Ogura
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2007-04-04       Impact factor: 3.117

8.  Rapid complexing of oxoacylglycerols with amino acids, peptides and aminophospholipids.

Authors:  J P Kurvinen; A Kuksis; A Ravandi; O Sjövall; H Kallio
Journal:  Lipids       Date:  1999-03       Impact factor: 1.880

9.  Phospholipids and oxophospholipids in atherosclerotic plaques at different stages of plaque development.

Authors:  Amir Ravandi; Saeid Babaei; Ramsey Leung; Juan Carlos Monge; George Hoppe; Henry Hoff; Hiroshi Kamido; Arnis Kuksis
Journal:  Lipids       Date:  2004-02       Impact factor: 1.880

Review 10.  Oxidized cholesteryl esters and inflammation.

Authors:  Soo-Ho Choi; Dmitri Sviridov; Yury I Miller
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2016-06-29       Impact factor: 4.698

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.